The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature Review

1Noble-Bell G, Cox A. Management of diabetic ketoacidosis in adults. Nurs Times. 2014;110(10):14-17. Noble-Bell G Cox A Management of diabetic ketoacidosis in adults Nurs Times 2014110 10 14 17Search in Google Scholar

2Westerberg DP. Diabetic ketoacidosis: evaluation and treatment. Am Fam Physician. 2013;87(5):337-346. Westerberg DP Diabetic ketoacidosis: evaluation and treatment Am Fam Physician 201387 5 337 346Search in Google Scholar

3Koye DN, Magliano DJ, Nelson RG, Pavkov ME. The Global Epidemiology of Diabetes and Kidney Disease. Adv Chronic Kidney Dis. 2018;25(2):121-132. Koye DN Magliano DJ Nelson RG Pavkov ME The Global Epidemiology of Diabetes and Kidney Disease Adv Chronic Kidney Dis 201825 2 121 13210.1053/j.ackd.2017.10.011Search in Google Scholar

4Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine (Abingdon). 2014;42(12):698-702. Forouhi NG Wareham NJ Epidemiology of diabetes Medicine (Abingdon) 201442 12 698 702Search in Google Scholar

5Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. 2020;162:108142. Hussain A Bhowmik B do Vale Moreira NC COVID-19 and diabetes: Knowledge in progress Diabetes Res Clin Pract 202016210814210.1016/j.diabres.2020.108142Search in Google Scholar

6Rauf A, Abu-Izneid T, Olatunde A, et al. COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies. Int J Environ Res Public Health. 2020;17(21):E8155. Published 2020 Nov 4. Rauf A Abu-Izneid T Olatunde A et al COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies Int J Environ Res Public Health 202017 21 E8155 Published 2020 Nov 410.3390/ijerph17218155Search in Google Scholar

7Bouhanick B, Cracowski J-L, Faillie J-L. Diabetes and COVID-19. Therapies. 2020;75(4):327-333. Bouhanick B Cracowski J-L Faillie J-L Diabetes and COVID-19 Therapies 202075 4 327 33310.1016/j.therap.2020.05.006Search in Google Scholar

8Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14(4):303-310. Singh AK Gupta R Ghosh A Misra A Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations Diabetes Metab Syndr 202014 4 303 31010.1016/j.dsx.2020.04.004719512032298981Search in Google Scholar

9Abdi A, Jalilian M, Sarbarzeh PA, Vlaisavljevic Z. Diabetes and COVID-19: A systematic review on the current evidences. Diabetes Res Clin Pract. 2020;166:108347. Abdi A Jalilian M Sarbarzeh PA Vlaisavljevic Z Diabetes and COVID-19: A systematic review on the current evidences Diabetes Res Clin Pract 202016610834710.1016/j.diabres.2020.108347Search in Google Scholar

10Varikasuvu SR, Dutt N, Thangappazham B, Varshney S. Diabetes and COVID-19: A pooled analysis related to disease severity and mortality. Prim Care Diabetes. 2020;S1751-9918(20)30251-5. Varikasuvu SR Dutt N Thangappazham B Varshney S Diabetes and COVID-19: A pooled analysis related to disease severity and mortality. Prim Care Diabetes 2020S1751-9918(20)30251-5Search in Google Scholar

11Orioli L, Hermans MP, Thissen JP, Maiter D, Vandeleene B, Yombi JC. COVID-19 in diabetic patients: Related risks and specifics of management. Annales d’Endocrinologie. 2020;81(2-3):101109. Orioli L Hermans MP Thissen JP Maiter D Vandeleene B Yombi JC COVID-19 in diabetic patients: Related risks and specifics of management Annales d’Endocrinologie 202081 2-3 10110910.1016/j.ando.2020.05.001Search in Google Scholar

12Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. The Lancet Diabetes and Endocrinology. 2020;8(9):782-792. Apicella M Campopiano MC Mantuano M Mazoni L Coppelli A del Prato S COVID-19 in people with diabetes: understanding the reasons for worse outcomes The Lancet Diabetes and Endocrinology 20208 9 782 79210.1016/S2213-8587(20)30238-2Search in Google Scholar

13Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730-174 Zhang JJ Dong X Cao YY et al Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China Allergy 202075 7 1730 17410.1111/all.1423832077115Search in Google Scholar

14Guo W, Li M, Dong Y, et al. diabetes is a risk factor for the progression and prognosis of COVID-19 [published online ahead of print, 2020 Mar 31]. Diabetes Metab Res Rev. 2020;e3319. Guo W Li M Dong Y et al diabetes is a risk factor for the progression and prognosis of COVID-19 [published online ahead of print, 2020 Mar 31] Diabetes Metab Res Rev 2020e3319Search in Google Scholar

15Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14(4):303-310. Singh AK Gupta R Ghosh A Misra A Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations Diabetes Metab Syndr 202014 4 303 31010.1016/j.dsx.2020.04.004Search in Google Scholar

16Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Pro-inflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004;53(8):2079-2086. Stentz FB Umpierrez GE Cuervo R Kitabchi AE Pro-inflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises Diabetes 200453 8 2079 208610.2337/diabetes.53.8.2079Search in Google Scholar

17Wang ZH, Kihl-Selstam E, Eriksson JW. Ketoacidosis occurs in both Type 1 and Type 2 diabetes--a population-based study from Northern Sweden. Diabet Med. 2008;25(7):867-870. Wang ZH Kihl-Selstam E Eriksson JW Ketoacidosis occurs in both Type 1 and Type 2 diabetes--a population-based study from Northern Sweden Diabet Med 200825 7 867 87010.1111/j.1464-5491.2008.02461.xSearch in Google Scholar

18Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):10541062. Zhou F Yu T Du R et al Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 2020395 10229 1054106210.1016/S0140-6736(20)30566-3Search in Google Scholar

19Croft A, Bucca A, Jansen JH, et al. First-time Diabetic Ketoacidosis in Type 2 Diabetics With Covid-19 Infection: A Novel Case Series. J Emerg Med. 2020;S0736-4679(20)30699-5. Croft A Bucca A Jansen JH et al First-time Diabetic Ketoacidosis in Type 2 Diabetics With Covid-19 Infection: A Novel Case Series J Emerg Med 2020S0736-4679(20)30699-510.1016/j.jemermed.2020.07.017Search in Google Scholar

20Pal R, Banerjee M, Yadav U, Bhattacharjee S. Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of the literature. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(6):15631569. Pal R Banerjee M Yadav U Bhattacharjee S Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of the literature Diabetes and Metabolic Syndrome: Clinical Research and Reviews 202014 6 1563156910.1016/j.dsx.2020.08.015Search in Google Scholar

21Umpierrez GE, Kitabchi AE. Diabetic ketoacidosis: risk factors and management strategies. Treat Endocrinol. 2003;2(2):95108. Umpierrez GE Kitabchi AE Diabetic ketoacidosis: risk factors and management strategies Treat Endocrinol 20032 2 9510810.2165/00024677-200302020-00003Search in Google Scholar

22Ehrmann D, Kulzer B, Roos T, Haak T, Al-Khatib M, Hermanns N. Risk factors and prevention strategies for diabetic ketoacidosis in people with established Type 1 diabetes. Lancet Diabetes Endocrinol. 2020;8(5):436-446. Ehrmann D Kulzer B Roos T Haak T Al-Khatib M Hermanns N Risk factors and prevention strategies for diabetic ketoacidosis in people with established Type 1 diabetes Lancet Diabetes Endocrinol 20208 5 436 44610.1016/S2213-8587(20)30042-5Search in Google Scholar

23Klein SL, Dhakal S, Ursin RL, Deshpande S, Sandberg K, Mauvais-Jarvis F. Biological sex impacts COVID-19 outcomes. PLoS Pathog. 2020;16(6):e1008570. Klein SL Dhakal S Ursin RL Deshpande S Sandberg K Mauvais-Jarvis F Biological sex impacts COVID-19 outcomes PLoS Pathog 202016 6 e100857010.1371/journal.ppat.1008570730772532569293Search in Google Scholar

24Goldman N, Fink D, Cai J, Lee YN, Davies Z. High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care. Diabetes Res Clin Pract. 2020;166:108291. Goldman N Fink D Cai J Lee YN Davies Z High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care Diabetes Res Clin Pract 202016610829110.1016/j.diabres.2020.108291732368032615280Search in Google Scholar

25Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes, Obesity and Metabolism. 2020;22(10):1935-1941. Li J Wang X Chen J Zuo X Zhang H Deng A COVID-19 infection may cause ketosis and ketoacidosis Diabetes, Obesity and Metabolism 202022 10 1935 194110.1111/dom.14057726468132314455Search in Google Scholar

26Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222-232. Umpierrez G Korytkowski M Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia Nat Rev Endocrinol 201612 4 222 23210.1038/nrendo.2016.1526893262Search in Google Scholar

27Dhatariya K. Diabetic ketoacidosis and hyperosmolar crisis in adults. Medicine. 2014;42(12):723-726. Dhatariya K Diabetic ketoacidosis and hyperosmolar crisis in adults Medicine 201442 12 723 72610.1016/j.mpmed.2014.09.012Search in Google Scholar

28Chan KH, Thimmareddygari D, Ramahi A, Atallah L, Baranetsky NG, Slim J. Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series. Diabetes Res Clin Pract. 2020;166:108279. Chan KH Thimmareddygari D Ramahi A Atallah L Baranetsky NG Slim J Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series Diabetes Res Clin Pract 202016610827910.1016/j.diabres.2020.108279731468532592843Search in Google Scholar

29Mackay IM, Arden KE. MERS coronavirus: diagnostics, epidemiology and transmission. Virol J. 2015;12:222. Mackay IM Arden KE MERS coronavirus: diagnostics, epidemiology and transmission Virol J 20151222210.1186/s12985-015-0439-5468737326695637Search in Google Scholar

30Shi X, Gong E, Gao D, et al. Severe acute respiratory syndrome-associated coronavirus is detected in intestinal tissues of fatal cases. Am J Gastroenterol. 2005;100(1):169-176. Shi X Gong E Gao D et al Severe acute respiratory syndrome-associated coronavirus is detected in intestinal tissues of fatal cases Am J Gastroenterol 2005100 1 169 17610.1111/j.1572-0241.2005.40377.x15654797Search in Google Scholar

31Alqahtani FY, Aleanizy FS, Ali El Hadi Mohamed R, et al. prevalence of comorbidities in Middle East respiratory syndrome coronavirus cases: a retrospective study. Epidemiol Infect. 2018;147:1-5. Alqahtani FY Aleanizy FS Ali El Hadi Mohamed R et al prevalence of comorbidities in Middle East respiratory syndrome coronavirus cases: a retrospective study Epidemiol Infect 20181471 510.1017/S0950268818002923651860330394248Search in Google Scholar

32Kulcsar KA, Coleman CM, Beck SE, Frieman MB. Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI Insight. 2019;4(20):e131774. Kulcsar KA Coleman CM Beck SE Frieman MB Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection JCI Insight 20194 20 e13177410.1172/jci.insight.131774682444331550243Search in Google Scholar

33Hofmann H, Pyrc K, van der Hoek L, Geier M, Berkhout B, Pöhlmann S. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci US A. 2005;102(22):7988-7993. Hofmann H Pyrc K van der Hoek L Geier M Berkhout B Pöhlmann S Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry Proc Natl Acad Sci US A 2005102 22 7988 799310.1073/pnas.0409465102114235815897467Search in Google Scholar

34Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47(3):193-199. Yang JK Lin SS Ji XJ Guo LM Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes Acta Diabetol 201047 3 193 19910.1007/s00592-009-0109-4708816419333547Search in Google Scholar

35Carlsson PO, Berne C, Jansson L. Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia. 1998;41(2):127-133. Carlsson PO Berne C Jansson L Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats Diabetologia 199841 2 127 13310.1007/s0012500508809498644Search in Google Scholar

36Pal R, Bhadada SK. COVID-19 and diabetes mellitus: an unholy interaction of two pandemics. Diabetes Metab Syndr 2020;14:513e7 Pal R Bhadada SK COVID-19 and diabetes mellitus: an unholy interaction of two pandemics Diabetes Metab Syndr 202014513e710.1016/j.dsx.2020.04.049720283732388331Search in Google Scholar

37Palermo NE, Sadhu AR, McDonnell ME. Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations. The Journal of clinical endocrinology and metabolism. 2020;105(8):1-11. Palermo NE Sadhu AR McDonnell ME Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations The Journal of clinical endocrinology and metabolism 2020105 8 1 1110.1210/clinem/dgaa360733786932556147Search in Google Scholar

38Chen X, Zhao B, Qu Y, et al. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019. Clin Infect Dis. 2020;71(8):1937-1942. Chen X Zhao B Qu Y et al Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019 Clin Infect Dis 202071 8 1937 194210.1093/cid/ciaa449718435432301997Search in Google Scholar

39Azamfirei L, Gurzu S, Solomon R, et al. Vascular endothelial growth factor: a possible mediator of endothelial activation in acute respiratory distress syndrome. Minerva Anestesiol. 2010;76(8):609-616. Azamfirei L Gurzu S Solomon R et al Vascular endothelial growth factor: a possible mediator of endothelial activation in acute respiratory distress syndrome Minerva Anestesiol 201076 8 609 616Search in Google Scholar

40Dietz W, Santos-Burgoa C. Obesity and its Implications for COVID-19 Mortality. Obesity (Silver Spring). 2020;28(6):1005. Dietz W Santos-Burgoa C Obesity and its Implications for COVID-19 Mortality Obesity (Silver Spring) 202028 6 100510.1002/oby.2281832237206Search in Google Scholar

41Tilinca M., Barabas-Hajdu E., Ferencz G., Nemes-Nagy E. Involvement of inflammatory cytokines in obesity and its complications, Revista Romana de Medicina de Laborator. 2018;26(3):359-372. Tilinca M. Barabas-Hajdu E. Ferencz G. Nemes-Nagy E Involvement of inflammatory cytokines in obesity and its complications Revista Romana de Medicina de Laborator 201826 3 359 37210.2478/rrlm-2018-0019Search in Google Scholar

42Tilinca M, Pal S, Preg Z, Barabas-Hajdu E, Tilinca R, German-Sallo M, Nemes-Nagy E. The relationship of metabolic and endocrine parameters with associated diseases in diabetes mellitus. Rev Chim. 2018;69(5):1288-1291. Tilinca M Pal S Preg Z Barabas-Hajdu E Tilinca R German-Sallo M Nemes-Nagy E The relationship of metabolic and endocrine parameters with associated diseases in diabetes mellitus Rev Chim 201869 5 1288 129110.37358/RC.18.5.6311Search in Google Scholar

43Nicola P, Ardeleanu E, Gadau C, et al. Evaluation of Biochemical and Clinical Parameters of Hypertension with Type 2 Diabetes Mellitus. Revista de Chimie. 2018;1(9):2402-2406. Nicola P Ardeleanu E Gadau C et al Evaluation of Biochemical and Clinical Parameters of Hypertension with Type 2 Diabetes Mellitus Revista de Chimie 20181 9 2402 240610.37358/RC.18.9.6542Search in Google Scholar

44Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-260. Zheng YY Ma YT Zhang JY Xie X COVID-19 and the cardiovascular system Nat Rev Cardiol 202017 5 259 26010.1038/s41569-020-0360-5709552432139904Search in Google Scholar

45Li B, Yang J, Zhao F, et al. prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-538. Li B Yang J Zhao F et al prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China Clin Res Cardiol 2020109 5 531 53810.1007/s00392-020-01626-9708793532161990Search in Google Scholar

46Evans K. Diabetic ketoacidosis: Update on management. Clinical Medicine, Journal of the Royal College of Physicians of London. 2019;19(5):396-398. Evans K Diabetic ketoacidosis: Update on management Clinical Medicine, Journal of the Royal College of Physicians of London 201919 5 396 39810.7861/clinmed.2019-0284677134231530688Search in Google Scholar

47Misra S, Oliver NS. Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis. Diabet Med. 2015;32(1):14-23. Misra S Oliver NS Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis Diabet Med 201532 1 14 2310.1111/dme.12604Search in Google Scholar

48Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev. 2016;(1):CD011281. Andrade-Castellanos CA Colunga-Lozano LE Delgado-Figueroa N Gonzalez-Padilla DA Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis Cochrane Database Syst Rev 2016 1 CD01128110.1002/14651858.CD011281Search in Google Scholar

49Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335-1343. Kitabchi AE Umpierrez GE Miles JM Fisher JN Hyperglycemic crises in adult patients with diabetes Diabetes Care 200932 7 1335 134310.2337/dc09-9032Search in Google Scholar

50Korytkowski M, Antinori-Lent K, Drincic A, et al. A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic. J Clin Endocrinol Metab. 2020;105(9):dgaa342. Korytkowski M Antinori-Lent K Drincic A et al A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic J Clin Endocrinol Metab 2020105 9 dgaa34210.1210/clinem/dgaa342Search in Google Scholar

51Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119-1131. Moghissi ES Korytkowski MT DiNardo M et al American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control Diabetes Care 200932 6 1119 113110.2337/dc09-9029Search in Google Scholar

52Chen D, Li X, Song Q, et al. Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China. JAMA Netw Open. 2020;3(6):e2011122. Chen D Li X Song Q et al Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China JAMA Netw Open 20203 6 e201112210.1001/jamanetworkopen.2020.11122Search in Google Scholar

53Ditzel J, Lervang HH. Disturbance of inorganic phosphate metabolism in diabetes mellitus: clinical manifestations of phosphorus-depletion syndrome during recovery from diabetic ketoacidosis. Diabetes Metab Syndr Obes. 2010;3:319-324. Ditzel J Lervang HH Disturbance of inorganic phosphate metabolism in diabetes mellitus: clinical manifestations of phosphorus-depletion syndrome during recovery from diabetic ketoacidosis Diabetes Metab Syndr Obes 20103319 32410.2147/DMSO.S13476Search in Google Scholar

54Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. The unique characteristics of COVID-19 coagulopathy. Crit Care. 2020;24(1):360. Iba T Levy JH Connors JM Warkentin TE Thachil J Levi M The unique characteristics of COVID-19 coagulopathy Crit Care 202024 1 36010.1186/s13054-020-03077-0Search in Google Scholar

55The Lancet Haematology. COVID-19 coagulopathy: an evolving story. Lancet Haematol. 2020;7(6):e425. The Lancet Haematology COVID-19 coagulopathy: an evolving story Lancet Haematol 20207 6 e42510.1016/S2352-3026(20)30151-4Search in Google Scholar

56Thibault, R., Seguin, P., Tamion, F. et al. Nutrition of the COVID-19 patient in the intensive care unit (ICU): a practical guidance.Crit Care 2020; 24, 447 Thibault R. Seguin P. Tamion F. et al Nutrition of the COVID-19 patient in the intensive care unit (ICU): a practical guidance Crit Care 2020 24 44710.1186/s13054-020-03159-z736944232684170Search in Google Scholar

57Shang Y, Pan C, Yang X, et al. management of critically ill patients with COVID-19 in ICU: a statement from front-line intensive care experts in Wuhan, China. Ann Intensive Care. 2020;10(1):73. Shang Y Pan C Yang X et al management of critically ill patients with COVID-19 in ICU: a statement from front-line intensive care experts in Wuhan, China Ann Intensive Care 202010 1 7310.1186/s13613-020-00689-1727565732506258Search in Google Scholar

58Rayman G, Lumb A, Kennon B, et al. Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID-19 pandemic. Diabet Med. 2020;37(7):1214-1216. Rayman G Lumb A Kennon B et al Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID-19 pandemic Diabet Med 202037 7 1214 121610.1111/dme.14328727674332421882Search in Google Scholar

59Kitabchi AE, Umpierrez GE, Murphy MB, et al. management of hyperglycemic crises in patients with diabetes. Diabetes Care. 2001;24(1):131-153. Kitabchi AE Umpierrez GE Murphy MB et al management of hyperglycemic crises in patients with diabetes Diabetes Care 200124 1 131 15310.2337/diacare.24.1.13111194218Search in Google Scholar

60Poston JT, Patel BK, Davis AM. Management of Critically Ill Adults With COVID-19. JAMA. 2020;323(18):1839-1841. Poston JT Patel BK Davis AM Management of Critically Ill Adults With COVID-19 JAMA 2020323 18 1839 184110.1001/jama.2020.491432215647Search in Google Scholar

61Wilcox SR. Management of respiratory failure due to covid-19. BMJ. 2020;369:m1786. Wilcox SR Management of respiratory failure due to covid-19 BMJ 2020369m178610.1136/bmj.m178632366375Search in Google Scholar

62Alhazzani W, Møller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med. 2020:1-34. Alhazzani W Møller MH Arabi YM et al Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19) Intensive Care Med 20201 34Search in Google Scholar